Published in Neurosurgery on March 01, 2005
Temporal lobe arteriovenous malformations: anatomical subtypes, surgical strategy, and outcomes. J Neurosurg (2013) 2.02
A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery (2010) 2.01
The ARUBA trial: current status, future hopes. Stroke (2010) 1.22
Cerebellar arteriovenous malformations: anatomic subtypes, surgical results, and increased predictive accuracy of the supplementary grading system. Neurosurgery (2012) 1.20
Brain Vascular Malformation Consortium: Overview, Progress and Future Directions. J Rare Disord (2013) 1.12
Deep arteriovenous malformations in the Basal Ganglia, thalamus, and insula: microsurgical management, techniques, and results. Neurosurgery (2013) 1.03
Radiosurgery facilitates resection of brain arteriovenous malformations and reduces surgical morbidity. Neurosurgery (2009) 0.93
Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment. Neurosurgery (2007) 0.84
Microsurgery for intracranial arteriovenous malformation: Long-term outcomes in 445 patients. PLoS One (2017) 0.75
Management of unbled brain arteriovenous malformation study. Neurol Clin (2015) 0.75
Diagnosis and evaluation of intracranial arteriovenous malformations. Surg Neurol Int (2015) 0.75
Sylvian fissure arteriovenous malformations: long-term prognosis and risk factors. Neurosurg Rev (2013) 0.75
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol (2006) 8.02
Body mass index and risk for end-stage renal disease. Ann Intern Med (2006) 7.56
Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45
Should the Babinski sign be part of the routine neurologic examination? Neurology (2005) 5.57
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int (2009) 5.28
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12
The beautiful and ethereal neurological exam: an appeal for research. Ann Neurol (2011) 4.10
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med (2009) 4.05
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol (2004) 3.82
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Risk of stroke in children: ethnic and gender disparities. Neurology (2003) 3.47
Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol (2009) 3.28
Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol (2012) 3.23
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology (2012) 3.20
MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell (2010) 3.18
Global variation in the relative burden of stroke and ischemic heart disease. Circulation (2011) 3.02
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med (2005) 2.90
Differences in simple morphological variables in ruptured and unruptured middle cerebral artery aneurysms. J Neurosurg (2012) 2.89
Ethics and sample size. Am J Epidemiol (2005) 2.88
Financial anatomy of neuroscience research. Ann Neurol (2006) 2.71
A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med (2013) 2.70
Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke (2006) 2.68
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
NIH disease funding levels and burden of disease. PLoS One (2011) 2.56
Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int (2005) 2.54
Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med (2008) 2.49
Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke (2004) 2.42
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care (2002) 2.34
Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol (2002) 2.34
Aneurysm growth occurs at region of low wall shear stress: patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke (2008) 2.32
Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics (2007) 2.29
Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke (2003) 2.28
Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26
Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care (2004) 2.25
Ultrasound visibility of needles used for regional nerve block: an in vitro study. Reg Anesth Pain Med (2004) 2.19
Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol (2006) 2.17
Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med (2012) 2.14
Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke (2003) 2.07
Influence of physician specialty on outcomes after acute ischemic stroke. J Hosp Med (2008) 2.07
Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery (2012) 2.06
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation (2008) 2.05
Validation of the supplemented Spetzler-Martin grading system for brain arteriovenous malformations in a multicenter cohort of 1009 surgical patients. Neurosurgery (2015) 2.05
Getting youth in the game: can we accelerate training for clinician-scientists? Ann Neurol (2010) 2.04
Abortion and mental health: findings from The National Comorbidity Survey-Replication. Obstet Gynecol (2014) 2.02
Temporal lobe arteriovenous malformations: anatomical subtypes, surgical strategy, and outcomes. J Neurosurg (2013) 2.02
A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery (2010) 2.01
Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive. Stroke (2013) 2.01
Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A (2007) 2.01
Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol (2010) 1.96
Recent trauma and acute infection as risk factors for childhood arterial ischemic stroke. Ann Neurol (2012) 1.94
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice. Cancer Prev Res (Phila) (2010) 1.91
Moyamoya disease in Washington State and California. Neurology (2005) 1.88
Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke (2008) 1.88
Thirty-year projections for deaths from ischemic stroke in the United States. Stroke (2003) 1.86
Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86
Critical roles of macrophages in the formation of intracranial aneurysm. Stroke (2010) 1.85
Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke (2011) 1.84
Declining stroke rates in Californian children with sickle cell disease. Blood (2004) 1.83
Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. AJR Am J Roentgenol (2007) 1.83
Antibiotic treatment of acute respiratory infections in acute care settings. Acad Emerg Med (2006) 1.82
Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res (2006) 1.81
Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke (2002) 1.80
Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. Science (2010) 1.79
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke (2003) 1.78
Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke (2005) 1.78
Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74
Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73
Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms: the CARAT study. Stroke (2008) 1.72
A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke (2011) 1.72
Translational research for a new administration: what sort of change to believe in? Ann Neurol (2008) 1.71
Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke (2010) 1.71
Biology of vascular malformations of the brain. Stroke (2009) 1.70
Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ (2009) 1.70
Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery (2008) 1.69